AR
AREV Life Sciences Global Corp
AREVF · OTC
$0.00 +0.00% (+$0.00)
Market Cap $22.6K
P/E Ratio -
Div. Yield -
ROE -
Analýza
AI report o byznysu, financích, ocenění, sentimentu, zprávách a rizicích - napsaný během několika minut.
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/S 0.46x
EV/FFO N/A
P/E N/A
Growth
0 /100
Declining Rev. growth 36.81%
Book val. growth N/A
EPS growth N/A
Profitability
20 /100
Weak Op. margin 2,827.74%
Gross margin 59.33%
FCF margin 745.62%
Quality
61 /100
Average Asset turnover 0.19x
ROIC 150.34%
ROA 571.63%
Debt
50 /100
Moderate Net debt/EBITDA -0.02x
Current ratio 0.06x
Int. coverage -236.17x
Stability
16 /100
Unstable EPS volatility 39.57%
Beta 4.94x
Profitable years 0
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na AREVF
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Michael C. Withrow
Employees
19,534
Headquarters
Coquitlam